Moderna

Latest Stories

FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. An influential scientific panel on Tuesday, Dec. 1, is set to tackle one of the most pressing questions in the U.S. coronavirus epidemic: When the first doses of COVID-19 vaccine become available, who should be at the front of the line for shots? (AP Photo/Hans Pennink, File)

US panel: 1st vaccines to health care workers, nursing homes

By MIKE STOBBE - Associated Press

California plans for arrival of first virus vaccine doses

By AMY TAXIN - Associated Press

In this photo provided by the Michigan Office of the Governor, Michigan Gov. Gretchen Whitmer addresses the state during a speech in Lansing, Mich., Tuesday, Dec. 1, 2020. (Michigan Office of the Governor via AP)

Cautious optimism, uncertainty as state virus cases decline

By DAVID EGGERT - Associated Press

A COVID-19 test is handed through the vehicle window at a mobile testing site on Tuesday, Dec. 1, 2020, in Long Beach, Calif. (AP Photo/Ashley Landis)

Key dates as US regulators weigh emergency use of vaccines

By The Associated Press - Associated Press

FILE - In this Aug. 23, 2020, file photo Food and Drug Administration commissioner Dr. Stephen Hahn speaks during a media briefing in the James Brady Briefing Room of the White House in Washington. Hahn, the head of the agency responsible for approving any COVID-19 vaccine, was summoned to the White House Tuesday, Dec. 1, as an increasingly frustrated President Donald Trump complained that approval hasn't moved faster. (AP Photo/Alex Brandon, File)

Pushed to rush, FDA head says feds will get vaccine ‘right’

By JONATHAN LEMIRE, JILL COLVIN and MATTHEW PERRONE and ZEKE MILLER - Associated Press

Prime Minister Justin Trudeau holds a press conference at Rideau Cottage during the COVID pandemic in Ottawa on Tuesday, Dec. 1, 2020. (Sean Kilpatrick/The Canadian Press via AP)

Canada: US border measures to last until virus under control

By ROB GILLIES - Associated Press

Moderna asked federal regulators for emergency approval Monday for a coronavirus vaccine. The company said its vaccine was 94% effective in its final analysis. (Associated Press)

CDC hosting panel to vote on who will get first doses of coronavirus vaccine

By Tom Howell Jr. - The Washington Times

Senate Majority Leader Mitch McConnell, R-Ky., arrives to talk to reporters after a Republican Conference luncheon, on Capitol Hill in Washington, Tuesday, Nov. 17, 2020. (AP Photo/J. Scott Applewhite) **FILE**

McConnell urges action on coronavirus relief as Congress returns from break

By Gabriella Muñoz - The Washington Times

Moderna says new results show its COVID-19 vaccine works well, and it will seek emergency regulatory

Associated Press

Director of the National Intellectual Property Rights Coordination Center Steve Francis, speaks during an interview with The Associated Press, Tuesday, Nov. 24, 2020, in Arlington, Va. (AP Photo/Alex Brandon)

Beware of COVID-19 scams as vaccine approaches FDA approval

By COLLEEN LONG - Associated Press

A currency trader watches monitors at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Friday, Nov. 27, 2020. Asian stock markets declined Friday as questions about the effectiveness of one possible coronavirus vaccine weighed on investor optimism. (AP Photo/Ahn Young-joon)

Asian stocks gain on stronger Chinese factory data

By JOE McDONALD - Associated Press

In this undated file photo issued by the University of Oxford on Monday, Nov. 23, 2020, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. With major COVID-19 vaccines showing high levels of protection, British officials are cautiously — and they stress cautiously — optimistic that life may start returning to normal by early April. (University of Oxford/John Cairns via AP, File)

COVID-19 vaccines’ scary side effects must not be dismissed

By Cheryl K. Chumley - The Washington Times

In this undated file photo issued by the University of Oxford on Monday, Nov. 23, 2020, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. With major COVID-19 vaccines showing high levels of protection, British officials are cautiously — and they stress cautiously — optimistic that life may start returning to normal by early April. (University of Oxford/John Cairns via AP, File)

AstraZeneca vaccine to be assessed amid dosing error questions

By Jill Lawless - Associated Press

UK asks regulator to assess AZ-Oxford vaccine amid questions

By JILL LAWLESS - Associated Press

Editorial Roundup: Tennessee

By The Associated Press - Associated Press

In this Tuesday, Nov. 17, 2020 file photo, manager Yllka Murati waits for a delivery driver to pick up takeout orders behind a partition displaying a sign to remind customers to wear a mask, at the Penrose Diner, in south Philadelphia. Despite the expected arrival of COVID-19 vaccines in just a few weeks, it could take several months — probably well into 2021 — before things get back to something close to normal in the U.S. and Americans can once again go to the movies, cheer at an NBA game or give Grandma a hug. (AP Photo/Matt Slocum, File) **FILE**

Keep the mask: A vaccine won’t end the US crisis right away

By CANDICE CHOI - Associated Press

Ohio governor: State’s first vaccine batch coming by Dec. 15

By ANDREW WELSH-HUGGINS - Associated Press

This Thursday, April 23, 2020, file screen grab taken from video issued by Britain's Oxford University shows a person being injected as part of the first human trials in the U.K. to test a potential coronavirus vaccine, untaken by Oxford University in England. AstraZeneca says late-stage trials of its COVID-19 vaccine were “highly effective’’ in preventing disease. A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday, Nov. 23, 2020. (Oxford University Pool via AP, File)

AstraZeneca reports promising results from coronavirus vaccine trial

By Tom Howell Jr. - The Washington Times

This photo shows from Aztec Media LLC shows online educational company Test Prep Insight CEO John Ross posing in Auburn, Calif., in February, 2020. Promising news about a coronavirus vaccine has small business owners feeling more upbeat despite the virus's continuing spread. Ross intends to hold off on any major changes. (Megan Hesson/Aztec Media LLC via AP)

Business owners upbeat about vaccine, wary as virus spreads

By JOYCE M. ROSENBERG - Associated Press

Dolly Parton helped fund a COVID-19 vaccine

By ALLIE CLOUSE and Knoxville News Sentinel - Associated Press